A. Ahr

2.7k total citations
56 papers, 1.9k citations indexed

About

A. Ahr is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, A. Ahr has authored 56 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 16 papers in Molecular Biology and 16 papers in Cancer Research. Recurrent topics in A. Ahr's work include Breast Cancer Treatment Studies (10 papers), HER2/EGFR in Cancer Research (8 papers) and Cancer Genomics and Diagnostics (7 papers). A. Ahr is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), HER2/EGFR in Cancer Research (8 papers) and Cancer Genomics and Diagnostics (7 papers). A. Ahr collaborates with scholars based in Germany, United States and Estonia. A. Ahr's co-authors include Manfred Kaufmann, Thomas Karn, Uwe Holtrich, Achim Rody, Christine Solbach, R. Gaetje, Lars Hanker, Dirk Metzler, Cornelia Liedtke and Eugen Ruckhaeberle and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and PLoS ONE.

In The Last Decade

A. Ahr

53 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Ahr Germany 19 1.1k 759 666 300 289 56 1.9k
Nnennaya Kanu United Kingdom 18 815 0.7× 621 0.8× 1.0k 1.6× 362 1.2× 354 1.2× 32 1.8k
Melanie Trivett Australia 13 1.0k 0.9× 695 0.9× 1.2k 1.9× 289 1.0× 382 1.3× 16 2.4k
Armelle Degeorges France 18 776 0.7× 562 0.7× 747 1.1× 117 0.4× 404 1.4× 34 1.6k
Stefanie Avril United States 22 801 0.7× 418 0.6× 649 1.0× 415 1.4× 189 0.7× 45 1.7k
Charles Decraene France 22 596 0.5× 571 0.8× 645 1.0× 140 0.5× 251 0.9× 40 1.4k
Jaana Lahti‐Domenici United States 13 1.1k 1.0× 750 1.0× 1.3k 1.9× 269 0.9× 252 0.9× 13 2.3k
Patrick Healy United States 24 970 0.9× 392 0.5× 592 0.9× 491 1.6× 520 1.8× 98 2.0k
Karen Zwaenepoel Belgium 26 870 0.8× 753 1.0× 929 1.4× 271 0.9× 587 2.0× 67 2.0k
Nikita Makretsov Canada 14 593 0.5× 380 0.5× 682 1.0× 164 0.5× 164 0.6× 19 1.4k
Henryk Pilch Germany 22 716 0.7× 421 0.6× 653 1.0× 505 1.7× 123 0.4× 56 1.7k

Countries citing papers authored by A. Ahr

Since Specialization
Citations

This map shows the geographic impact of A. Ahr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Ahr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Ahr more than expected).

Fields of papers citing papers by A. Ahr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Ahr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Ahr. The network helps show where A. Ahr may publish in the future.

Co-authorship network of co-authors of A. Ahr

This figure shows the co-authorship network connecting the top 25 collaborators of A. Ahr. A scholar is included among the top collaborators of A. Ahr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Ahr. A. Ahr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ikenberg, Hans, et al.. (2023). Comparison of the Hologic Genius Digital Diagnostics System with the ThinPrep Imaging System—A retrospective assessment. Cancer Cytopathology. 131(7). 424–432. 30 indexed citations
2.
El‐Balat, Ahmed, Nicole Sänger, Thomas Karn, et al.. (2018). Claudin-1 is linked to presence of implants and micropapillary pattern in serous borderline epithelial tumours of the ovary. Journal of Clinical Pathology. 71(12). 1060–1064. 9 indexed citations
3.
Hanker, Lars, Achim Rody, Uwe Holtrich, et al.. (2012). Prognostic evaluation of the B cell/IL-8 metagene in different intrinsic breast cancer subtypes. Breast Cancer Research and Treatment. 137(2). 407–416. 30 indexed citations
4.
Karn, Thomas, Lajos Pusztai, Eugen Ruckhäberle, et al.. (2011). Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation. European Journal of Cancer. 48(1). 12–23. 39 indexed citations
5.
Rody, Achim, Uwe Holtrich, L. Pusztai, et al.. (2009). T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers. Breast Cancer Research. 11(2). R15–R15. 336 indexed citations
6.
Ruckhäberle, Eugen, Thomas Karn, Knut Engels, et al.. (2009). Prognostic impact of thymidine phosphorylase expression in breast cancer – Comparison of microarray and immunohistochemical data. European Journal of Cancer. 46(3). 549–557. 18 indexed citations
7.
Rody, Achim, Uwe Holtrich, R. Gaetje, et al.. (2007). Poor Outcome in Estrogen Receptor–Positive Breast Cancers Predicted by Loss of Plexin B1. Clinical Cancer Research. 13(4). 1115–1122. 54 indexed citations
9.
Gräf, Christine, Klara Brixius, Freerk T. Baumann, A. Ahr, & Klaus Schüle. (2006). The Role of Physical Activity in the Prevention and Rehabilitation of Breast Cancer. Breast Care. 1(5). 310–314. 3 indexed citations
10.
Ahr, A., Achim Rody, Stephan Kissler, Martina Kaufmann, & R. Gätje. (2006). Risikofaktoren der Rezidivhäufigkeit von vulvären intraepithelialen Neoplasien Grad III (VIN III). Zentralblatt für Gynäkologie. 128(6). 347–351. 8 indexed citations
11.
Ahr, A., et al.. (2006). Outcome of preterm and term neonates of mothers with malignant diseases diagnosed during pregnancy. The Journal of Maternal-Fetal & Neonatal Medicine. 19(2). 101–103. 7 indexed citations
12.
Ahr, A., Uwe Holtrich, Thomas Karn, et al.. (2006). Identifikation von Präeklampsiepatientinnen mittels cDNA-Genexpressionsprofilen an humanen Plazentaproben und Serum - eine Pilotstudie. Zentralblatt für Gynäkologie. 128(3). 138–142. 2 indexed citations
13.
Kissler, Stefan, Joachim Kohl, Anja Müeller, et al.. (2004). Uterine contractility and directed sperm transport assessed by hysterosalpingoscintigraphy (HSSG) and intrauterine pressure (IUP) measurement. Acta Obstetricia Et Gynecologica Scandinavica. 83(4). 369–374. 34 indexed citations
14.
Schmidt‐Kittler, Oleg, Thomas Ragg, Martin Granzow, et al.. (2003). From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression. Proceedings of the National Academy of Sciences. 100(13). 7737–7742. 493 indexed citations
15.
Bremerich, Dorothee H., et al.. (2003). An�sthesiologische Versorgung von HIV-positiven Schwangeren zur elektiven Sectio caesarea. Der Anaesthesist. 52(12). 1124–1131. 11 indexed citations
16.
Bremerich, Dorothee H., Rolf Schlößer, Ralf P. Brandes, et al.. (2003). Mepivacaine for Spinal Anesthesia in Parturients Undergoing Elective Cesarean Delivery: Maternal and Neonatal Plasma Concentrations and Neonatal Outcome. Zentralblatt für Gynäkologie. 125(12). 518–521. 2 indexed citations
17.
Ahr, A., Uwe Holtrich, Christine Solbach, et al.. (2001). Molecular classification of breast cancer patients by gene expression profiling*. The Journal of Pathology. 195(3). 312–320. 57 indexed citations
18.
Ahr, A., Anton Scharl, Gϋnter von Minckwitz, et al.. (1999). Cross-reactive staining of normal bone-marrow cells by monoclonal antibody 2E11. International Journal of Cancer. 84(5). 502–505. 11 indexed citations
19.
Ahr, A., et al.. (1995). P53 protein in 204 patients with primary breast carcinoma ? immunohistochemical detection and clinical value as a prognostic factor. Archives of Gynecology and Obstetrics. 256(3). 139–146. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026